AURO LABORATORIES LTD. Share Price
AURO LABORATORIES LTD. Share Price Today
As of 25 Jul 2026, AURO LABORATORIES LTD. share price is ₹244.00. The stock opened at ₹241.00, compared to its previous close of ₹240.50. During today's trading session, AURO LABORATORIES LTD. share price moved in the range of ₹240.00 to ₹244.80, with an average price of ₹242.40 for the day. Looking at its last 52-week, the stock has touched a low of ₹159.00 and a high of ₹317.00.
AURO LABORATORIES LTD. Returns Calculator
AURO LABORATORIES LTD. Shareholder Returns
AURO LABORATORIES LTD. Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,65,711.00 | 36.73 | 5.05 | 14.85% | 0.55 | 18.72% | 18.85 | 0.91% | 0.56 | 10.90 |
| Divis Laboratories | 1,93,860.00 | 61.36 | 9.40 | 16.19% | 0.00 | 21.00% | 9.43 | 0.50% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,92,687.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,12,593.00 | 33.55 | 3.27 | 11.27% | 0.00 | 14.95% | 423.36 | 0.93% | 0.44 | 43.52 |
| Zydus Lifesciences | 1,11,082.00 | 17.39 | 3.23 | 19.69% | 0.35 | 20.30% | 3.70 | 0.11% | 0.39 | 35.38 |
| Lupin | 1,09,553.00 | 19.83 | 4.71 | 27.01% | 0.03 | 27.44% | 3.51 | 0.78% | 0.61 | 129.18 |
| Mankind Pharma | 1,05,607.00 | 1.05 | 0.12 | 12.65% | 0.42 | 12.97% | 5.05 | 0.05% | 0.54 | 49.37 |
| Dr. Reddy's Laboratories | 97,364.90 | 30.58 | 2.56 | 11.07% | 0.18 | 12.54% | 377.96 | 0.69% | 0.41 | 38.68 |
| Aurobindo Pharma | 88,508.40 | 25.27 | 2.34 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 84,727.30 | 60.26 | 10.10 | 18.21% | 0.40 | 16.70% | 97.21 | 0.12% | 0.64 | 13.72 |
AURO LABORATORIES LTD. Financials
Income Statement · Consolidated
| Particulars | Mar 2025 |
|---|---|
| Revenue | 20.06 |
| Operating profit | 1.88 |
| Net profit | 1.84 |
Income Statement · Standalone
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | ₹30.74 | ₹19.12 | ₹53.64 | ₹52.89 |
| Other Income | ₹2.01 | ₹0.93 | ₹1.50 | ₹0.94 |
| Total Revenue | ₹32.75 | ₹20.05 | ₹55.14 | ₹53.84 |
| Total Expenses | ₹27.80 | ₹18.17 | ₹44.79 | ₹50.39 |
| Profit Before Tax | ₹4.81 | ₹1.88 | ₹10.35 | ₹3.45 |
| Tax | ₹1.28 | ₹0.04 | ₹2.55 | ₹1.00 |
| Profit After Tax | ₹3.53 | ₹1.84 | ₹7.79 | ₹2.44 |
| EPS - Basic | ₹5.67 | ₹2.95 | ₹12.50 | ₹3.92 |
| EPS - Diluted | ₹5.67 | ₹2.95 | ₹12.50 | ₹3.92 |
Cash Flow · Standalone
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Profit before tax | ₹4.81 | ₹1.88 | ₹10.35 | ₹3.45 |
| Income before WC changes | ₹11.92 | ₹3.78 | ₹12.43 | ₹5.58 |
| Change in Assets | -₹8.86 | ₹8.32 | ₹4.04 | -₹8.01 |
| Change in Liabilities | -₹0.95 | -₹6.36 | ₹2.34 | ₹5.72 |
| Change in WC | -₹9.81 | ₹1.96 | ₹6.38 | -₹2.30 |
| Cash flow from Operations | ₹2.11 | ₹5.02 | ₹18.81 | ₹3.28 |
| Cash flow from Investing | -₹14.78 | -₹23.70 | -₹38.67 | -₹5.08 |
| Cash flow from Financing | ₹14.04 | ₹17.69 | ₹19.09 | -₹8.18 |
| Total Cash Flow | ₹1.37 | -₹0.99 | -₹0.77 | -₹9.98 |
| Cash (Start of the year) | ₹0.00 | ₹0.99 | ₹2.42 | ₹12.40 |
| Cash (End of the year) | ₹1.37 | ₹0.00 | ₹1.65 | ₹2.42 |
Balance Sheet · Standalone
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Non-Current Assets | ₹90.32 | ₹78.23 | ₹54.88 | ₹20.33 |
| Current Assets | ₹30.77 | ₹20.87 | ₹30.85 | ₹35.66 |
| Total Assets | ₹121.08 | ₹99.10 | ₹85.73 | ₹55.99 |
| Current Liabilities | ₹28.55 | ₹21.64 | ₹23.93 | ₹18.13 |
| Net Current Asset | ₹2.21 | -₹0.77 | ₹6.92 | ₹17.53 |
| Non-Current Liabilities | ₹46.18 | ₹34.49 | ₹19.84 | ₹3.66 |
| Equity Capital | ₹46.35 | ₹42.97 | ₹41.96 | ₹34.20 |
| Total Equity & Liabilities | ₹121.08 | ₹99.10 | ₹85.73 | ₹55.99 |
About AURO LABORATORIES LTD.
Auro Laboratories Limited is an India-based company, which is engaged in the manufacturing activities of active pharmaceutical ingredients (APIs). The Company is specializing in producing anti-diabetics like Metformin HCL, which is used in the treatment of type 2 diabetes. It also undertakes toll/custom manufacturing for API's and intermediates on a contract basis. The Company's API products include antihistamine, muscle relaxant, diuretic, iron deficiency, anti-diabetics, anti-fungal, anti-ulcer, iodine supplement, anti-malaria, analgesics, antacids, anti-inflammatory, specialty chemicals and others. Its intermediate products include glibenclamde sulphonamide, cis-bramo benzoate, cls-tosylate, 2-ethoxy benzoic acid, 2-ethoxy benzoic acid, among others. It offers its manufacturing and technical services, such as process scale up, process optimization, custom synthesis and custom manufacturing. It exports to Southeast Asia, Middle East and several European countries.
AURO LABORATORIES LTD. Financial Highlights
- Revenue: AURO LABORATORIES LTD. reported revenue of ₹32.75 crore in FY26 vs ₹20.06 crore in FY25. It showed an increase of 63.26% on a yearly basis.
- Operating Profit: AURO LABORATORIES LTD. reported an operating profit of ₹4.81 crore in FY26 vs ₹1.88 crore in FY25. It showed an increase of 155.85% on a year-on-year basis.
- Net Profit: AURO LABORATORIES LTD. reported a net profit of ₹3.53 crore in FY26 vs ₹1.84 crore in FY25. It showed an increase of 91.85% on a yearly basis.
AURO LABORATORIES LTD. Quarterly Result Highlights
- AURO LABORATORIES LTD. reported revenue of ₹9.82 crore in Sep 2025, compared with ₹3.19 crore in Jun 2025, representing an increase of 207.84% on a quarter-on-quarter (QoQ) basis.
- AURO LABORATORIES LTD. reported an operating profit of ₹1.72 crore in Sep 2025, compared with ₹0.11 crore in Jun 2025, representing an increase of 1,663.64% on a quarter-on-quarter (QoQ) basis.
- AURO LABORATORIES LTD. reported a profit of ₹0.72 crore in Sep 2025, compared with ₹0.11 crore in Jun 2025, reflecting an increase of 754.55% on a QoQ basis.
Similar Stocks
FAQs on AURO LABORATORIES LTD. Share Price
What is AURO LABORATORIES LTD. share price today?
AURO LABORATORIES LTD. share price is ₹244.00 as on 24 Jul, 2026, 15:28 IST.
How has the AURO LABORATORIES LTD. share price performed in the past?
In the last 1 year, AURO LABORATORIES LTD. delivered a return of -12.47%. The AURO LABORATORIES LTD. share price hit a high of ₹317.00 and low of ₹159.00.
How much is the Mutual Fund shareholding in AURO LABORATORIES LTD. shares?
The Mutual Fund Shareholding in AURO LABORATORIES LTD. was 0.01% at the end of Jun 2026.
What is the the 52-week high and low of AURO LABORATORIES LTD. shares ?
The 52-week high and low of AURO LABORATORIES LTD. share is ₹317.00 and ₹159.00 as of 24 Jul, 2026.
What is the market cap of AURO LABORATORIES LTD.?
The market capitalisation of AURO LABORATORIES LTD. is ₹152.01 Crores as on 24 Jul, 2026.
What are the stock symbols of AURO LABORATORIES LTD.?
The stock symbol of AURO LABORATORIES LTD. is 530233 on the BSE, and the ISIN is INE292C01011.
What was yesterday's closing price for AURO LABORATORIES LTD. shares ?
AURO LABORATORIES LTD. shares closed yesterday at ₹240.50 on BSE
How to buy AURO LABORATORIES LTD. shares?
To buy AURO LABORATORIES LTD. shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy AURO LABORATORIES LTD. shares on Holidays?
No, shares of AURO LABORATORIES LTD. or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell AURO LABORATORIES LTD. shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of AURO LABORATORIES LTD.?
The PE and PB ratio of AURO LABORATORIES LTD. is 81.53 and 3.49 respectively, as on 24 Jul, 2026, 15:28 IST.